Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial-Reference-Cited by-同舟云学术

Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial

Published:2015-10-21 Issue:3 Volume:37 Page:245-252
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:Eur Heart J

Author:

Kubica Jacek,Adamski Piotr,Ostrowska Małgorzata,Sikora Joanna,Kubica Julia Maria,Sroka Wiktor Dariusz,Stankowska Katarzyna,Buszko Katarzyna,Navarese Eliano Pio,Jilma Bernd,Siller-Matula Jolanta Maria,Marszałł Michał Piotr,Rość Danuta,Koziński Marek

Funder

Collegium Medicum of Nicolaus Copernicus University

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine

Link

http://academic.oup.com/eurheartj/article-pdf/37/3/245/7532086/ehv547.pdf

Reference20 articles.

1. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes

2. Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes

3. O'Gara PT Kushner FG Ascheim DD Casey DE Jr Chung MK de Lemos JA Ettinger SM Fang JC Fesmire FM Franklin BA Granger CB Krumholz HM Linderbaum JA Morrow DA Newby LK Ornato JP Ou N Radford MJ Tamis-Holland JE Tommaso CL Tracy CM Woo YJ Zhao DX Anderson JL Jacobs AK Halperin JL Albert NM Brindis RG Creager MA DeMets D Guyton RA Hochman JS Kovacs RJ Kushner FG Ohman EM Stevenson WG Yancy CW , American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013;127:e362–e425.